Selected research
Market Structure
Global Mycoplasma Detection System Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Mycoplasma Detection System market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Mycoplasma Detection System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Mycoplasma Detection System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Mycoplasma Detection System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Mycoplasma Detection System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Mycoplasma Detection System include Thermo Fisher Scientific, Transgen Biotech Co, Sartorius, R and D Systems, Merck, Lonza, InvivoGen, Eurofins and Charles River Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Mycoplasma Detection System market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Mycoplasma Detection System and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Mycoplasma Detection System sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Mycoplasma Detection System market size, projected growth trends, production technologies, key applications, and end-use industries.
Mycoplasma Detection System Segment by Company
Thermo Fisher Scientific
Transgen Biotech Co
Sartorius
R and D Systems
Merck
Lonza
InvivoGen
Eurofins
Charles River Laboratories
BioMérieux
Applied Biological Materials Inc
Agilent Technologies
Mycoplasma Detection System Segment by Type
PCR Based Systems
Luminescence Based Systems
Others
Mycoplasma Detection System Segment by Application
Pharmaceutical Companies
Academic Research Institutes
Others
Mycoplasma Detection System Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mycoplasma Detection System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Mycoplasma Detection System and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mycoplasma Detection System.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Mycoplasma Detection System market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Mycoplasma Detection System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Mycoplasma Detection System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Mycoplasma Detection System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- PCR Based Systems
- Luminescence Based Systems
- Others
Applications
- Pharmaceutical Companies
- Academic Research Institutes
- Others
Companies covered
- Thermo Fisher Scientific
- Transgen Biotech Co
- Sartorius
- R and D Systems
- Merck
- Lonza
- InvivoGen
- Eurofins
- Charles River Laboratories
- BioMérieux
- Applied Biological Materials Inc
- Agilent Technologies
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Mycoplasma Detection System Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Mycoplasma Detection System Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Mycoplasma Detection System Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Mycoplasma Detection System Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Mycoplasma Detection System Market Dynamics
- 2.1 Mycoplasma Detection System Industry Trends
- 2.2 Mycoplasma Detection System Industry Drivers
- 2.3 Mycoplasma Detection System Industry Opportunities and Challenges
- 2.4 Mycoplasma Detection System Industry Restraints
3 Mycoplasma Detection System Market by Manufacturers
- 3.1 Global Mycoplasma Detection System Revenue by Manufacturers (2021-2026)
- 3.2 Global Mycoplasma Detection System Sales by Manufacturers (2021-2026)
- 3.3 Global Mycoplasma Detection System Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Mycoplasma Detection System Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Mycoplasma Detection System Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Mycoplasma Detection System Manufacturers, Product Type & Application
- 3.7 Global Mycoplasma Detection System Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Mycoplasma Detection System Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Mycoplasma Detection System Players Market Share by Revenue in 2025
- 3.8.3 2025 Mycoplasma Detection System Tier 1, Tier 2, and Tier 3
4 Mycoplasma Detection System Market by Type
- 4.1 Mycoplasma Detection System Type Introduction
- 4.1.1 PCR Based Systems
- 4.1.2 Luminescence Based Systems
- 4.1.3 Others
- 4.2 Global Mycoplasma Detection System Sales by Type
- 4.2.1 Global Mycoplasma Detection System Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Mycoplasma Detection System Sales by Type (2021-2032)
- 4.2.3 Global Mycoplasma Detection System Sales Market Share by Type (2021-2032)
- 4.3 Global Mycoplasma Detection System Revenue by Type
- 4.3.1 Global Mycoplasma Detection System Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Mycoplasma Detection System Revenue by Type (2021-2032)
- 4.3.3 Global Mycoplasma Detection System Revenue Market Share by Type (2021-2032)
5 Mycoplasma Detection System Market by Application
- 5.1 Mycoplasma Detection System Application Introduction
- 5.1.1 Pharmaceutical Companies
- 5.1.2 Academic Research Institutes
- 5.1.3 Others
- 5.2 Global Mycoplasma Detection System Sales by Application
- 5.2.1 Global Mycoplasma Detection System Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Mycoplasma Detection System Sales by Application (2021-2032)
- 5.2.3 Global Mycoplasma Detection System Sales Market Share by Application (2021-2032)
- 5.3 Global Mycoplasma Detection System Revenue by Application
- 5.3.1 Global Mycoplasma Detection System Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Mycoplasma Detection System Revenue by Application (2021-2032)
- 5.3.3 Global Mycoplasma Detection System Revenue Market Share by Application (2021-2032)
6 Global Mycoplasma Detection System Sales by Region
- 6.1 Global Mycoplasma Detection System Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Mycoplasma Detection System Sales by Region (2021-2032)
- 6.2.1 Global Mycoplasma Detection System Sales by Region (2021-2026)
- 6.2.2 Global Mycoplasma Detection System Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Mycoplasma Detection System Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Mycoplasma Detection System Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Mycoplasma Detection System Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Mycoplasma Detection System Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Mycoplasma Detection System Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Mycoplasma Detection System Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Mycoplasma Detection System Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Mycoplasma Detection System Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Mycoplasma Detection System Revenue by Region
- 7.1 Global Mycoplasma Detection System Revenue by Region
- 7.1.1 Global Mycoplasma Detection System Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Mycoplasma Detection System Revenue by Region (2021-2026)
- 7.1.3 Global Mycoplasma Detection System Revenue by Region (2027-2032)
- 7.1.4 Global Mycoplasma Detection System Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Mycoplasma Detection System Revenue (2021-2032)
- 7.2.2 North America Mycoplasma Detection System Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Mycoplasma Detection System Revenue (2021-2032)
- 7.3.2 Europe Mycoplasma Detection System Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Mycoplasma Detection System Revenue (2021-2032)
- 7.4.2 Asia-Pacific Mycoplasma Detection System Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Mycoplasma Detection System Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Mycoplasma Detection System Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Thermo Fisher Scientific
- 8.1.1 Thermo Fisher Scientific Company Information
- 8.1.2 Thermo Fisher Scientific Business Overview
- 8.1.3 Thermo Fisher Scientific Mycoplasma Detection System Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Thermo Fisher Scientific Mycoplasma Detection System Product Portfolio
- 8.1.5 Thermo Fisher Scientific Recent Developments
- 8.2 Transgen Biotech Co
- 8.2.1 Transgen Biotech Co Company Information
- 8.2.2 Transgen Biotech Co Business Overview
- 8.2.3 Transgen Biotech Co Mycoplasma Detection System Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Transgen Biotech Co Mycoplasma Detection System Product Portfolio
- 8.2.5 Transgen Biotech Co Recent Developments
- 8.3 Sartorius
- 8.3.1 Sartorius Company Information
- 8.3.2 Sartorius Business Overview
- 8.3.3 Sartorius Mycoplasma Detection System Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Sartorius Mycoplasma Detection System Product Portfolio
- 8.3.5 Sartorius Recent Developments
- 8.4 R and D Systems
- 8.4.1 R and D Systems Company Information
- 8.4.2 R and D Systems Business Overview
- 8.4.3 R and D Systems Mycoplasma Detection System Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 R and D Systems Mycoplasma Detection System Product Portfolio
- 8.4.5 R and D Systems Recent Developments
- 8.5 Merck
- 8.5.1 Merck Company Information
- 8.5.2 Merck Business Overview
- 8.5.3 Merck Mycoplasma Detection System Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Merck Mycoplasma Detection System Product Portfolio
- 8.5.5 Merck Recent Developments
- 8.6 Lonza
- 8.6.1 Lonza Company Information
- 8.6.2 Lonza Business Overview
- 8.6.3 Lonza Mycoplasma Detection System Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Lonza Mycoplasma Detection System Product Portfolio
- 8.6.5 Lonza Recent Developments
- 8.7 InvivoGen
- 8.7.1 InvivoGen Company Information
- 8.7.2 InvivoGen Business Overview
- 8.7.3 InvivoGen Mycoplasma Detection System Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 InvivoGen Mycoplasma Detection System Product Portfolio
- 8.7.5 InvivoGen Recent Developments
- 8.8 Eurofins
- 8.8.1 Eurofins Company Information
- 8.8.2 Eurofins Business Overview
- 8.8.3 Eurofins Mycoplasma Detection System Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Eurofins Mycoplasma Detection System Product Portfolio
- 8.8.5 Eurofins Recent Developments
- 8.9 Charles River Laboratories
- 8.9.1 Charles River Laboratories Company Information
- 8.9.2 Charles River Laboratories Business Overview
- 8.9.3 Charles River Laboratories Mycoplasma Detection System Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Charles River Laboratories Mycoplasma Detection System Product Portfolio
- 8.9.5 Charles River Laboratories Recent Developments
- 8.10 BioMérieux
- 8.10.1 BioMérieux Company Information
- 8.10.2 BioMérieux Business Overview
- 8.10.3 BioMérieux Mycoplasma Detection System Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 BioMérieux Mycoplasma Detection System Product Portfolio
- 8.10.5 BioMérieux Recent Developments
- 8.11 Applied Biological Materials Inc
- 8.11.1 Applied Biological Materials Inc Company Information
- 8.11.2 Applied Biological Materials Inc Business Overview
- 8.11.3 Applied Biological Materials Inc Mycoplasma Detection System Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Applied Biological Materials Inc Mycoplasma Detection System Product Portfolio
- 8.11.5 Applied Biological Materials Inc Recent Developments
- 8.12 Agilent Technologies
- 8.12.1 Agilent Technologies Company Information
- 8.12.2 Agilent Technologies Business Overview
- 8.12.3 Agilent Technologies Mycoplasma Detection System Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Agilent Technologies Mycoplasma Detection System Product Portfolio
- 8.12.5 Agilent Technologies Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Mycoplasma Detection System Value Chain Analysis
- 9.1.1 Mycoplasma Detection System Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Mycoplasma Detection System Production Mode & Process
- 9.2 Mycoplasma Detection System Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Mycoplasma Detection System Distributors
- 9.2.3 Mycoplasma Detection System Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst